Literature DB >> 22841159

Estimated GFR and incident cardiovascular disease events in American Indians: the Strong Heart Study.

Nawar M Shara1, Hong Wang, Mihriye Mete, Yaman Rai Al-Balha, Nameer Azalddin, Elisa T Lee, Nora Franceschini, Stacey E Jolly, Barbara V Howard, Jason G Umans.   

Abstract

BACKGROUND: In populations with high prevalences of diabetes and obesity, estimating glomerular filtration rate (GFR) by using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation may predict cardiovascular disease (CVD) risk better than by using the Modification of Diet in Renal Disease (MDRD) Study equation. STUDY
DESIGN: Longitudinal cohort study comparing the association of GFR estimated using either the CKD-EPI or MDRD Study equation with incident CVD outcomes. SETTING & PARTICIPANTS: American Indians participating in the Strong Heart Study, a longitudinal population-based cohort with high prevalences of diabetes, CVD, and CKD. PREDICTOR: Estimated GFR (eGFR) predicted using the CKD-EPI and MDRD Study equations. OUTCOMES: Fatal and nonfatal cardiovascular events, consisting of coronary heart disease, stroke, and heart failure. MEASUREMENTS: The association between eGFR and outcomes was explored in Cox proportional hazards models adjusted for traditional risk factors and albuminuria; the net reclassification index and integrated discrimination improvement were determined for the CKD-EPI versus MDRD Study equations.
RESULTS: In 4,549 participants, diabetes was present in 45%; CVD, in 7%; and stages 3-5 CKD, in 10%. During a median of 15 years, there were 1,280 cases of incident CVD, 929 cases of incident coronary heart disease, 305 cases of incident stroke, and 381 cases of incident heart failure. Reduced eGFR (<90 mL/min/1.73 m2) was associated with adverse events in most models. Compared with the MDRD Study equation, the CKD-EPI equation correctly reclassified 17.0% of 2,151 participants without incident CVD to a lower risk (higher eGFR) category and 1.3% (n=28) were reclassified incorrectly to a higher risk (lower eGFR) category. LIMITATIONS: Single measurements of eGFR and albuminuria at study visits.
CONCLUSIONS: Although eGFR based on either equation had similar associations with incident CVD, coronary heart disease, stroke, and heart failure events, in those not having events, reclassification of participants to eGFR categories was superior using the CKD-EPI equation compared with the MDRD Study equation.
Copyright © 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22841159      PMCID: PMC3473098          DOI: 10.1053/j.ajkd.2012.06.015

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  30 in total

1.  General deming regression for estimating systematic bias and its confidence interval in method-comparison studies.

Authors:  R F Martin
Journal:  Clin Chem       Date:  2000-01       Impact factor: 8.327

2.  Risk factors for coronary heart disease in diabetic and nondiabetic Native Americans. The Strong Heart Study.

Authors:  B V Howard; T K Welty; R R Fabsitz; L D Cowan; A J Oopik; N A Le; J Yeh; P J Savage; E T Lee
Journal:  Diabetes       Date:  1992-10       Impact factor: 9.461

3.  The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods.

Authors:  E T Lee; T K Welty; R Fabsitz; L D Cowan; N A Le; A J Oopik; A J Cucchiara; P J Savage; B V Howard
Journal:  Am J Epidemiol       Date:  1990-12       Impact factor: 4.897

4.  Prediction of coronary heart disease in a population with high prevalence of diabetes and albuminuria: the Strong Heart Study.

Authors:  Elisa T Lee; Barbara V Howard; Wenyu Wang; Thomas K Welty; James M Galloway; Lyle G Best; Richard R Fabsitz; Ying Zhang; Jeunliang Yeh; Richard B Devereux
Journal:  Circulation       Date:  2006-06-12       Impact factor: 29.690

5.  Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004.

Authors:  Elizabeth Selvin; Jane Manzi; Lesley A Stevens; Frederick Van Lente; David A Lacher; Andrew S Levey; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2007-12       Impact factor: 8.860

6.  Rising tide of cardiovascular disease in American Indians. The Strong Heart Study.

Authors:  B V Howard; E T Lee; L D Cowan; R B Devereux; J M Galloway; O T Go; W J Howard; E R Rhoades; D C Robbins; M L Sievers; T K Welty
Journal:  Circulation       Date:  1999-05-11       Impact factor: 29.690

7.  The burden of chronic kidney disease among the Zuni Indians: the Zuni Kidney Project.

Authors:  Marina Scavini; Christine A Stidley; Susan S Paine; Vallabh O Shah; Francesca Tentori; Arlene Bobelu; Thomas K Welty; Jean W MacCluer; Philip G Zager
Journal:  Clin J Am Soc Nephrol       Date:  2007-04-18       Impact factor: 8.237

8.  Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study.

Authors:  B V Howard; E T Lee; L D Cowan; R R Fabsitz; W J Howard; A J Oopik; D C Robbins; P J Savage; J L Yeh; T K Welty
Journal:  Am J Epidemiol       Date:  1995-08-01       Impact factor: 4.897

9.  Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients - the Hong Kong diabetes registry.

Authors:  Xilin Yang; Ronald C Ma; Wing-Yee So; Gary T Ko; Alice P Kong; Christopher W Lam; Chun-Shun Ho; Clive S Cockram; Vivian C Wong; Peter C Tong; Juliana C Chan
Journal:  Cardiovasc Diabetol       Date:  2007-12-02       Impact factor: 9.951

10.  Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.

Authors:  Kunihiro Matsushita; Bakhtawar K Mahmoodi; Mark Woodward; Jonathan R Emberson; Tazeen H Jafar; Sun Ha Jee; Kevan R Polkinghorne; Anoop Shankar; David H Smith; Marcello Tonelli; David G Warnock; Chi-Pang Wen; Josef Coresh; Ron T Gansevoort; Brenda R Hemmelgarn; Andrew S Levey
Journal:  JAMA       Date:  2012-05-09       Impact factor: 56.272

View more
  19 in total

1.  Association of low-moderate urine arsenic and QT interval: Cross-sectional and longitudinal evidence from the Strong Heart Study.

Authors:  Katherine A Moon; Yiyi Zhang; Eliseo Guallar; Kevin A Francesconi; Walter Goessler; Jason G Umans; Lyle G Best; Barbara V Howard; Richard B Devereux; Peter M Okin; Ana Navas-Acien
Journal:  Environ Pollut       Date:  2018-05-26       Impact factor: 8.071

2.  Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D Study.

Authors:  Lene Ryom; Jens D Lundgren; Mike Ross; Ole Kirk; Matthew Law; Philippe Morlat; Eric Fontas; Colette Smit; Christoph A Fux; Camilla I Hatleberg; Stéphane de Wit; Caroline A Sabin; Amanda Mocroft
Journal:  J Infect Dis       Date:  2016-08-02       Impact factor: 5.226

3.  The association of urine arsenic with prevalent and incident chronic kidney disease: evidence from the Strong Heart Study.

Authors:  Laura Y Zheng; Jason G Umans; Fawn Yeh; Kevin A Francesconi; Walter Goessler; Ellen K Silbergeld; Karen Bandeen-Roche; Eliseo Guallar; Barbara V Howard; Virginia M Weaver; Ana Navas-Acien
Journal:  Epidemiology       Date:  2015-07       Impact factor: 4.822

4.  Urine arsenic and prevalent albuminuria: evidence from a population-based study.

Authors:  Laura Y Zheng; Jason G Umans; Maria Tellez-Plaza; Fawn Yeh; Kevin A Francesconi; Walter Goessler; Ellen K Silbergeld; Eliseo Guallar; Barbara V Howard; Virginia M Weaver; Ana Navas-Acien
Journal:  Am J Kidney Dis       Date:  2012-11-09       Impact factor: 8.860

5.  Arsenic metabolism and one-carbon metabolism at low-moderate arsenic exposure: Evidence from the Strong Heart Study.

Authors:  Miranda Jones Spratlen; Mary V Gamble; Maria Grau-Perez; Chin-Chi Kuo; Lyle G Best; Joseph Yracheta; Kevin Francesconi; Walter Goessler; Yasmin Mossavar-Rahmani; Meghan Hall; Jason G Umans; Amanda Fretts; Ana Navas-Acien
Journal:  Food Chem Toxicol       Date:  2017-05-04       Impact factor: 6.023

6.  Chronic arsenic exposure and risk of carotid artery disease: The Strong Heart Study.

Authors:  Farrah J Mateen; Maria Grau-Perez; Jonathan S Pollak; Katherine A Moon; Barbara V Howard; Jason G Umans; Lyle G Best; Kevin A Francesconi; Walter Goessler; Ciprian Crainiceanu; Eliseo Guallar; Richard B Devereux; Mary J Roman; Ana Navas-Acien
Journal:  Environ Res       Date:  2017-05-26       Impact factor: 6.498

7.  Multi-system trajectories and the incidence of heart failure in the Framingham Offspring Study.

Authors:  Cara E Guardino; Stephanie Pan; Ramachandran S Vasan; Vanessa Xanthakis
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

8.  The Association of Arsenic Exposure and Arsenic Metabolism With the Metabolic Syndrome and Its Individual Components: Prospective Evidence From the Strong Heart Family Study.

Authors:  Miranda J Spratlen; Maria Grau-Perez; Lyle G Best; Joseph Yracheta; Mariana Lazo; Dhananjay Vaidya; Poojitha Balakrishnan; Mary V Gamble; Kevin A Francesconi; Walter Goessler; Shelley A Cole; Jason G Umans; Barbara V Howard; Ana Navas-Acien
Journal:  Am J Epidemiol       Date:  2018-08-01       Impact factor: 4.897

9.  Replication of the effect of SLC2A9 genetic variation on serum uric acid levels in American Indians.

Authors:  V Saroja Voruganti; Nora Franceschini; Karin Haack; Sandra Laston; Jean W MacCluer; Jason G Umans; Anthony G Comuzzie; Kari E North; Shelley A Cole
Journal:  Eur J Hum Genet       Date:  2013-12-04       Impact factor: 4.246

10.  Glomerular filtration function decline, mortality, and cardiovascular events: data from the Strong Heart Study.

Authors:  Astrid M Suchy-Dicey; Ying Zhang; Sterling McPherson; Katherine R Tuttle; Barbara Howard; Jason Umans; Dedra S Buchwald
Journal:  Kidney360       Date:  2021-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.